See other companies on Welcome to the Jungle
Senda Biosciences
Programmable medicine platform
- 21-100 employees
- B2B
- Artificial Intelligence
- Biology
- MedTech
- North Cambridge, Cambridge, MA
Jump to section
Company mission
Senda Biosciences' mission is to bring life-changing treatments to patients by using nature’s codes to fully program medicines, potentially unlocking new levels of speed, breadth, and productivity in the development of advanced therapies.
Our take
Developing new medicines for currently untreatable conditions is a complex task requiring lengthy and resource-intensive trial and error. Whilst some precision medicine startups are rapidly increasing the rate of successful drug discovery, these usually focus on leveraging AI to understand a specific health problem, as opposed to focusing on understanding the human body as a whole.
Senda Biosciences provides a programmable medicine platform, allowing researchers to program information molecules such as mRNA, DNA, and siRNA for the development of new drugs. The platform targets natural nanoparticles to offer far more diverse targeting options than existing methods for both the analysis and the programming of cells.
Exchanging information from research to cells has long since been a significant challenge to precision medicine, but Senda Biosciences shows great potential to bridge this gap and facilitate cell programming across the entire human body. By facilitating such programming along with using machine learning to fuel an increasing understanding of the human body ‘programming language’, the company hopes to increase access and scope to the precision medicine sector.
Kirsty
Company Specialist at Welcome to the Jungle
Benefits
- Short- and long-term disability insurance
- Free lunches, snacks, and beverages
- Paid parental leave
- Employee stock option plan
- Comprehensive medical, dental, and vision plans
- Life insurance
- Retirement savings program
- Flexible time off policy
- Commuter benefit
- Regular company holidays
Company values
- Teamwork - We are one company, one team. We collaborate without silos, supporting and acknowledging one another to accomplish one mission
- Respect - Senda values respect above all else. We treat all our team members with mutual respect and sensitivity. We respect all individuals and value their contributions at Senda
- Pioneering Breakthroughs - With great science at our core, we continue to explore and challenge prevailing wisdom to improve and seek the cutting edge
- Patient-Focused - Patients are at the heart of all that we do here at Senda. We hold a responsibility to bring our vision of fully unlocking programmable medicines to a reality for them
Funding (last 2 of 3 rounds)
Aug 2022
$123m
SERIES C
Jun 2021
$55m
SERIES B
Total funding: $266m
Leadership
Guillaume Pfefer
(CEO)Experience as President and CEO of Kala Pharmaceuticals from 2012 to 2014. SVP and Global Vaccine Leader for GSK's Shingrix from 2015 to 2020.
John Casey, Jr.
(Head of Business Development)Co-founder and Senior Director of Science and Technology for Inari since 2016. Founder of Kintai Therapeautics since 2016.
Diversity, Equity & Inclusion at Senda Biosciences
- Senda Biosciences is an Equal Opportunity Employer. Senda does not discriminate on the basis of race, religion, color, sex, gender identity, sexual orientation, age, national origin, veteran status, or any other status protected under federal, state, or local law.